scholarly article | Q13442814 |
P356 | DOI | 10.1177/0961203311425524 |
P698 | PubMed publication ID | 22065097 |
P2093 | author name string | O Nived | |
C Bengtsson | |||
S Rantapää Dahlqvist | |||
M-L Ohman | |||
P2860 | cites work | Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus | Q46973423 |
Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 | ||
Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. | Q50561696 | ||
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus | Q28258975 | ||
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study | Q33387473 | ||
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study | Q34017775 | ||
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus | Q34338929 | ||
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review | Q37356697 | ||
Risk factors for development of coronary artery disease in women with systemic lupus erythematosus | Q37615743 | ||
Challenges in the diagnosis of the antiphospholipid syndrome | Q37723113 | ||
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. | Q40461525 | ||
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 | ||
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
Risk factors for cardiovascular disease in systemic lupus erythematosus | Q43767819 | ||
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study | Q44383942 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. | Q44612340 | ||
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 | ||
P433 | issue | 4 | |
P921 | main subject | Sweden | Q34 |
systemic lupus erythematosus | Q1485 | ||
circulatory system | Q11068 | ||
P304 | page(s) | 452-459 | |
P577 | publication date | 2011-11-07 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study | |
P478 | volume | 21 |
Q51120688 | A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex. |
Q40949132 | Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012. |
Q36153524 | Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q40562190 | Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study |
Q34061425 | Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients |
Q50571191 | Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. |
Q38830086 | Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care |
Q84311215 | Decreased heart rate variability in patients with psoriatic arthritis |
Q49072554 | Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus. |
Q38777078 | Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus |
Q38162490 | Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus |
Q58572438 | Etiologies des accidents vasculaires cérébraux ischémiques chez les jeunes: apport de l’interniste |
Q38736889 | Magnetic resonance imaging for characterizing myocardial diseases |
Q91868696 | Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome |
Q52668758 | Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. |
Q38230699 | Pathogenesis and treatment of atherosclerosis in lupus |
Q38899360 | Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus |
Q37598905 | Predictors of peripheral arterial disease in SLE change with patient's age. |
Q43900414 | Premature coronary heart disease in SLE: can we prevent progression? |
Q90000657 | Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China |
Q38764974 | Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study. |
Q36299359 | Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study |
Q34173514 | Risk of vascular events in patients with polymyalgia rheumatica |
Q37294162 | Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases |
Q47549484 | Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus. |
Q26771476 | Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies |
Q35530248 | Systemic lupus erythematosus and thrombosis |
Q92988199 | The Role of Neutrophils and Neutrophil Extracellular Traps in Vascular Damage in Systemic Lupus Erythematosus |
Q39283399 | The evolving concept of SLE comorbidities. |
Q52725381 | The non-haemostatic role of platelets in systemic lupus erythematosus. |
Q39039774 | The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study |
Q21285155 | Vascular disease in systemic lupus erythematosus |
Q41375519 | β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus. |
Search more.